Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

WALL TRANSFORMERS 74710 & 74910

K-Number: K771864 · 1977-11-22

ApplicantWelch Allyn, Inc.
Decision Date1977-11-22
Product CodeGCW
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

WALL TRANSFORMERS 74710 & 74910 is the device name listed in this FDA 510(k) record. The listed applicant is Welch Allyn, Inc.. It received FDA 510(k) clearance on 1977-11-22 under 510(k) number K771864. The device is classified under product code GCW. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the WALL TRANSFORMERS 74710 & 74910?

WALL TRANSFORMERS 74710 & 74910 is a medical device that received FDA 510(k) clearance on 1977-11-22. The listed applicant is Welch Allyn, Inc.. The 510(k) number is K771864.

When did WALL TRANSFORMERS 74710 & 74910 receive FDA 510(k) clearance?

WALL TRANSFORMERS 74710 & 74910 received FDA 510(k) clearance on 1977-11-22, under 510(k) number K771864.

Who is the listed applicant for WALL TRANSFORMERS 74710 & 74910?

The FDA 510(k) record lists Welch Allyn, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for WALL TRANSFORMERS 74710 & 74910?

The FDA product code for WALL TRANSFORMERS 74710 & 74910 is GCW.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Welch Allyn, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K243598Welch Allyn Connex® 360 (Multiple)K241411Welch Allyn Connex® Spot Monitor; 901058 Vital Signs Monitor Core (CSM)K223381iExaminer System with Panoptic PlusK212473Welch Allyn Connex Central StationK191013Welch Allyn Diagnostic Cardiology Suite 2.X.X with Spirometry optionK181016Welch Allyn RetinaVue Network REF 901108 PACS Medical Image System

View all 109 devices →

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑